Results 151 to 160 of about 11,371 (266)

From pill to pain: Alendronate‐induced esophageal injury—A case report and review

open access: yesJGH Open
Background Alendronate is used to treat Paget's bone disease, glucocorticoid‐induced osteoporosis, and postmenopausal osteoporosis because it suppresses osteoclast activity to stop bone resorption.
Zhen Fan   +6 more
doaj   +1 more source

Adult Paget's disease of bone. [PDF]

open access: yesClin Med (Lond), 2020
Tuck SP, Walker J.
europepmc   +1 more source

Genetic Determinants of Paget's Disease of Bone. [PDF]

open access: yesCurr Osteoporos Rep, 2021
Makaram NS, Ralston SH.
europepmc   +1 more source

Differenciáldiagnosztikai és prognosztikai markerek alkalmazása korai arthritisekben, különös tekintettel a rheumatoid arthritisre = Application of differential diagnostic and prognostic markers in early arthritides especially in rheumatoid arthritis [PDF]

open access: yes, 2007
Pályázatunkban differenciáldiagnosztikai és prognosztikai markerek alkalmazását tűztük ki célul korai arthritisekben, különös tekintettel a rheumatoid arthritisre (RA).
Gergely, Péter   +2 more
core  

Optineurin regulates NRF2-mediated antioxidant response in a mouse model of Paget's disease of bone. [PDF]

open access: yesSci Adv, 2023
Hu X   +12 more
europepmc   +1 more source

Novel UBA Domain Mutations of SQSTM1 in Paget's Disease of Bone: Genotype Phenotype Correlation, Functional Analysis, and Structural Consequences [PDF]

open access: bronze, 2004
Lynne J. Hocking   +13 more
openalex   +1 more source

Spastic Paraplegia with Paget's Disease of Bone due to a VCP Gene Mutation. [PDF]

open access: yesIntern Med, 2021
Nakamura T   +5 more
europepmc   +1 more source

Osteolytic Bone Loss and Skeletal Deformities in a Mouse Model for Early-Onset Paget's Disease of Bone with PFN1 Mutation Are Treatable by Alendronate. [PDF]

open access: yesPharmaceuticals (Basel), 2023
Ling Z   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy